Karyopharm Therapeutics Inc. · NASDAQ:KPTI
Goldman Sachs Group Inc reported a 6.30% stake in Karyopharm Therapeutics Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 11, 2026
Goldman Sachs Group Inc reported a 6.30% stake in Karyopharm Therapeutics Inc., 1,429,198 shares, as a passive investor on Jun 30, 2026. Filed Aug 11, 2026 (Schedule 13G/A).
- Stake
- 6.30%
- Shares
- 1,429,198
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| THE GOLDMAN SACHS GROUP, INC. | 6.30% | 1,429,198 |
| GOLDMAN SACHS & CO. LLC | 6.30% | 1,429,198 |
Source
Related
- Karyopharm Therapeutics Inc.
- Goldman Sachs Group Inc
- Karyopharm Therapeutics Inc. shareholders
- Schedule 13G · Goldman Sachs Group Inc · May 12, 2026
- Form 4 · Abate Kristin · Oct 19, 2026
- Schedule 13G/A · Anders Hove · Oct 8, 2026
- Form 4 · Abate Kristin · Oct 2, 2026
- Schedule 13G/A · Anders Hove · Sep 25, 2026
- Schedule 13G/A · Anders Hove · Sep 25, 2026